✦ LIBER ✦

ElevatedAPOBEC3BCorrelates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers

✍ Scribed by Sieuwerts, Anieta M.; Willis, Scooter; Burns, Michael B.; Look, Maxime P.; Gelder, Marion E. Meijer-Van; Schlicker, Andreas; Heideman, Marinus R.; Jacobs, Heinz; Wessels, Lodewyk; Leyland-Jones, Brian; Gray, Kathryn P.; Foekens, John A.; Harris, Reuben S.; Martens, John W. M.

Book ID: 126948226
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 728 KB
Volume: 5
Category: Article
ISSN: 1868-8497
DOI: 10.1007/s12672-014-0196-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3–55 Estrogen–Receptor Status and Outcom

3–55 Estrogen–Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node–Positive Breast Cancer

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Estrogen receptor status in CHEK2-positi

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

✍ C Cybulski; T Huzarski; T Byrski; J Gronwald; T Dębniak; A Jakubowska; B Górski; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

PO104 PATIENTS WITH DISCORDANCE IN ESTRO

PO104 PATIENTS WITH DISCORDANCE IN ESTROGEN RECEPTOR BETWEEN PRIMARY BREAST CANCERS AND RECURRENT TUMORS HAVE POOR OUTCOMES

✍ Akiyoshi, Sayuri; Koi, Yumiko; Igawa, Akiko; Saruwatari, Akihiro; Oikawa, Masahi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Cyclin D1 expression is associated with

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

✍ Kirsimari Aaltonen; Rose-Marie Amini; Göran Landberg; Hannaleena Eerola; Kristii 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 194 KB

High CCND1 amplification identifies a gr

High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

✍ Pankaj G. Roy; Norman Pratt; Colin A. Purdie; Lee Baker; Alison Ashfield; Phil Q 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 265 KB

## Abstract __CCND1__ encodes for the cyclin D1 protein involved in G1/S cell cycle transition. In breast cancer the mechanism of __CCND1__ amplification, relationship between cyclin D1 protein expression and the key clinical markers estrogen receptor (ER) and HER2 requires elucidation. Tissue micr

High genomic grade index associated with

High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy

✍ Yasuto Naoi; Kazuki Kishi; Tomonori Tanei; Ryo Tsunashima; Naoomi Tominaga; Yosu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB